GlobeNewsWire
21 Oct 2025, 12:00 UTC · 47w ago
Verdict
Headline takes no side. We score CDTX +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company presented positive Phase 2b clinical data showing significant efficacy and safety for its influenza preventative candidate CD388.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1d ago
Seeking Alpha
1d ago
+120.1%
Price agrees with the score
$221.38 vs $100.56 close before publication (Oct 20) · not market-adjusted
CDTX chart →
